Floatz logo

METHADONE

Opiate Addiction

University of Maryland, BaltimoreSmall moleculePhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Opiate Addiction cohort.

Asset / SponsorPhaseRating
Buprenorphine
Erin Winstanley
Phase 4BBB
NEPENTHE
Lyndra Inc.
Phase 4BB
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
University of California, San Francisco
Phase 4BB
Oxycodone
Member Companies of the Opioid PMR Consortium
Phase 4BB
OXYMORPHONE CII
Member Companies of the Opioid PMR Consortium
Phase 4B

Same molecule, other indications

METHADONE is also rated in:

substance-related disorderDormant
BBB
Indicative ·
78 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
75 / 100
View asset →
Chronic PainDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →